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Adenovirus (Ad) E1A is a potent oncogene and has been shown to deregulate the expression of a large number of cellular genes
leading to cellular transformation. Here we have analysed the expression of several immunomodulatory molecules on the surface of a set
of human cell lines transformed with either Ad12 or Ad5. Human cells transformed with Ad12 demonstrated reduced expression of cell
surface LFA-3, Fas and MHC class I when compared to Ad5-transformed cells. Furthermore, Ad12-transformed human cell lines
demonstrated greater susceptibility to lysis by lymphokine-activated killer (LAK) cells, compared to Ad5-transformed human cell lines. In
contrast, previous studies with rodent cells showed that both Ad5- and Ad12-transformed rat cells were susceptible to LAK cells. Thus,
transformation of human cells with Ad5 or Ad12 results in differences in the expression of immunomodulatory molecules on the cell
surface and differential recognition of these virus-transformed cells by immune effector cells.
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The E1 region of adenovirus (Ad) encodes the E1A and
E1B proteins that are necessary and sufficient for cell
transformation and have multiple functions, including the
subversion of cell cycle regulatory mechanisms (Gallimore
and Turnell, 2001; Sang et al., 2002) and evasion of host
immune responses (Blair and Blair Zajdel, 2004; Burgert et
al., 2002). It is well established that primary rodent cells can
be transformed by the E1A and E1B gene products of many
human adenoviruses, regardless of their serotype, and that
Ad-transformed cells form tumors when introduced into
immunodeficient rodents. Indeedmany of the key concepts in0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.05.017
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E-mail address: g.e.blair@leeds.ac.uk (G.E. Blair).oncogenic cell transformation have arisen from studies on the
E1A and E1B viral oncoproteins (Blair and Blair Zajdel,
2004). However, only cells transformed by species A
adenoviruses (such as Ad12) will form tumors when
introduced into immunocompetent rodents, whereas cells
transformed by species C adenoviruses (such as Ad2 or Ad5)
are non-oncogenic (Blair and Blair Zajdel, 2004; Raska,
1995). Expression of Ad12 E1A has been shown to lead to
down-regulation of major histocompatibility complex
(MHC) class I molecules on the surface of transformed rat
and human cells, whereas cells expressing Ad2 or Ad5 E1A
display normal or elevatedMHC class I molecules (Schrier et
al., 1983; Vasavada et al., 1986). The MHC class I gene
products are a highly polymorphic family of cell surface
proteins responsible for presentation of peptide antigens to
cytotoxic T cells. The oncogenicity of Ad12-transformed05) 297 – 308
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regulation of MHC class I and consequent evasion of T cell
immunity (Blair and Hall, 1998; Bernards et al., 1983).
In addition to cytotoxic Tcells, natural killer (NK) cells are
a major mediator of anti-viral immunity. Interleukin-2 (IL-2)
activation of peripheral blood mononuclear cells ex vivo
leads to the generation of a lymphokine-activated killer
(LAK) population with a high cytolytic activity attributed
to activated NK cells. It has been proposed that virus-
infected or virus-transformed cells are susceptible to NK
cell-mediated killing due to reduced levels of surface MHC
class I molecules, the so-called ‘‘missing-self’’ hypothesis
(Karlhofer et al., 1992; Ljunggren and Karre, 1990). NK cells
express a repertoire of inhibitory receptors that bind to target
cell MHC class I molecules (reviewed by Lanier, 1998;
Vilches and Parham, 2002). Down-regulation of MHC class I
expression results in a failure to engage these inhibitory
receptors, resulting in NK cell activation and destruction of
the target cell. Ad12-transformed cells with reduced MHC
class I expression would therefore be predicted to be
susceptible to NK cell-mediated lysis. However, previous
studies have shown that Ad5-transformed rodent cells are
susceptible to NK cell-mediated killing whereas Ad12-
transformed rodent cells are NK resistant (Cook et al.,
1986; Huvent et al., 1996; Kenyon and Raska, 1986; Raska
and Gallimore, 1982; Sawada et al., 1985). Furthermore, in
rodent model systems, LAK cells can kill Ad12-, Ad2- and
Ad5-transformed cells (Kenyon et al., 1991; Kenyon and
Raska, 1986). However, the susceptibility of Ad5- and Ad12-
transformed human cells in models of human NK cell-
mediated killing has not been reported.
Resistance to NK cytotoxicity has been demonstrated in
other viruses that down-regulate MHC class I expression. In
the case of human cytomegalovirus (HCMV) and Kaposi’s
sarcoma-associated herpesvirus (KSHV), down-regulation
of the lymphocyte function-associated antigen-3 (LFA-3)
and intercellular adhesion molecule-1 (ICAM-1) molecules,
respectively, reduce the susceptibility of infected cells to NK
cell killing (Fletcher et al., 1998; Ishido et al., 2000). It is
possible that modulation of target cell surface receptors may
also play a role in immune evasion by Ad-transformed cells.
Here we have evaluated the expression of the immuno-
modulatory molecules LFA-3, MHC class I and Fas by a
series of Ad5- and Ad12-transformed human cells and
determined the sensitivity of these cells to LAK cell-mediated
killing. The data revealed that Ad12-transformed cells
expressed lower levels of MHC class I, LFA-3 and Fas than
the Ad5-transformed cells. Furthermore, Ad12-transformed
human cells were more susceptible to LAK cell-mediated
cytolysis than Ad5-transformed cells.Results
This study utilised a panel of human cells, comprising
three Ad5- and three Ad12-transformed cell lines, an SV40-transformed cell line and also several non-virally trans-
formed cell lines. Four of the six Ad-transformed cell lines
had been established by transformation of human embryonic
retinoblasts (HER), derived from a single donor, with the E1
region of Ad12 or Ad5 (see Materials and methods). In
addition, the SV40-transformed cell line was established
from the same donor source of HER. The fifth Ad12-
transformed cell line (Ad12 HER 2) was also established in
a HER background but originated from a different donor.
The sixth cell line, 293, is a well-documented Ad5-trans-
formed human embryonic kidney cell line (Graham et al.,
1977). Although primary untransformed HER cells were not
available for analysis, the use of multiple cell lines trans-
formed with either the Ad12 or Ad5 E1A/E1B region
minimises possible effects of natural variation between any
two cell lines.
To confirm the expression of the appropriate viral
oncogenes, the six different Ad-transformed cells were
analysed for E1A and E1B 19-kDa protein expression by
immunoblotting (Fig. 1A). In the case of Ad5 E1A, two
major protein bands of approximately 30 kDa in size
were detected, corresponding to the 289 and 243 amino
acid species of Ad5 E1A (Boulanger and Blair, 1991).
The Ad12 E1A proteins produced a cluster of bands of
approximately 30 kDa. There was no cross-reaction of
the anti-Ad5 E1A antibody with Ad12 E1A proteins and
vice versa. Expression of the appropriate E1A mRNA
was confirmed by real-time RT-PCR analysis (results not
shown). Immunoblotting revealed the E1B 19-kDa protein
in all six adenovirus-transformed cell lines (Fig. 1B).
There was considerably more E1B 19-kDa protein
detected in the Ad5-than in the Ad12-transformed cell
lines. However, differences in E1B 19-kDa protein levels
detected by immunoblotting were not mirrored by levels
of E1B transcripts when analysed by quantitative RT-PCR
(Fig. 1B). While there was variation in the E1B transcript
levels, the large differences observed in E1B 19-kDa
protein by immunoblotting are likely to be due to
differences in antibody specificity. The antibody used in
E1B 19-kDa immunoblotting was raised against the Ad2
E1B protein (Blair Zajdel et al., 1985), which has 98%
identity to the Ad5 E1B 19-kDa amino acid sequence but
only 43% identity to the corresponding Ad12 protein
(Bos et al., 1981, and data not shown). These results
confirm the expression of the appropriate E1A and E1B
molecules in the different Ad-transformed cell lines
allowing us to investigate the roles which these adeno-
virus proteins play in regulating expression of immuno-
modulatory molecules and the susceptibility to LAK cells.
Expression of cell surface MHC class I molecules in
Ad5- and Ad12-transformed human cell lines
We next investigated the expression of surface MHC
class I by these cell lines using flow cytometry (Figs. 2A
and B). The three Ad12-transformed cell lines expressed
Fig. 1. Expression of adenovirus transforming gene products in adenovirus-transformed human cells. (A) Expression of Ad5 and Ad12 E1A and E1B 19-kDa
proteins, determined by immunoblotting. HaCaT, HER C SV40 T3.2 and BJAB cells were used as negative controls. The antisera used for immunoblotting are
indicated to the right of the blots. (B) Real-time PCR analysis of Ad5 and Ad12 E1B mRNA, shown as expression relative to GAPDH. Error bars represent one
standard deviation. Expression was measured in all cell lines, but where bars are not evident, mRNA levels were negligible.
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transformed cell lines (P values < 0.01). 293 cells
exhibited lower levels of surface MHC class I molecules
than the Ad5-transformed HER lines. Interestingly, 293cells have been described to have neuronal characteristics
(Shaw et al., 2002), which may explain their constitutive
low levels of class I molecules. Overall, the data obtained
are consistent with the transcriptional repression of MHC
Fig. 2. Surface expression of classical MHC class I molecules on control, Ad5- and Ad12-transformed human cell lines. (A) Flow cytometric analysis of
surface MHC class I (black histograms) compared to isotype-matched control (line histograms). (B) Average mean fluorescence intensity of surface MHC class
I molecules compared to isotype-matched control antibody. K562 cells were confirmed as being MHC class I negative (data not shown). Error bars represent
one standard deviation derived from six experiments.
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in agreement with previous studies obtained using Ad-
transformed rodent and human cells (Schrier et al., 1983;
Vasavada et al., 1986).
Cell surface ICAM-1, LFA-3 and Fas expression by
Ad12- and Ad5-transformed cells
The down-regulation of MHC class I is an immune
evasion mechanism utilised by several viruses including
HCMV and KSHV (Hewitt, 2003). In addition, the celladhesion molecules ICAM-1 and LFA-3 have both been
implicated in the mechanism of NK cell-mediated killing
and are down-regulated in HCMV- and KSHV-infected
cells, respectively (Fletcher et al., 1998; Ishido et al.,
2000). It was therefore of interest to determine whether
expression of these adhesion molecules is modulated by
adenoviruses as it is for these other human DNA viruses.
Expression of cell surface ICAM-1 was low or undetectable
on all lines of Ad-transformed cells (data not shown).
However, the Ad12-transformed cells expressed signifi-
cantly lower levels of cell surface LFA-3 than Ad5-
Fig. 3. Surface expression of LFA-3 molecules on control, Ad5- and Ad12-transformed human cell lines. (A) Flow cytometric analysis of LFA-3 (black
histograms) compared to isotype-matched control (line histograms). (B) Average mean fluorescence intensity of surface LFA-3 molecules compared to isotype-
matched control antibody. Error bars represent one standard deviation derived from six experiments. (C) Real-time PCR analysis of LFA-3 mRNA, normalised
to HaCaT cells. Error bars represent one standard deviation.
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cytometry (Figs. 3A and B).
Expression of E1A alone has been shown to increase the
susceptibility of cells to Fas-mediated apoptosis (Cook et al.,
1996). We therefore analysed the panel of Ad-transformed
and control human cell lines for surface Fas expression and
Fas-mediated apoptosis. Flow cytometry showed that while
Fas protein was detected on the surface of the three lines of
Ad12-transformed cells, there were much lower levels of Fas
than the three Ad5-transformed cell lines (P values < 0.006)
(Figs. 4A and B). To assess the susceptibility of the target
cells to Fas ligation, the cell lines were treated with an anti-
Fas antibody that is capable of inducing apoptosis. Despite
differences in expression of Fas between Ad5- and Ad12-
transformed cell lines, apoptosis was not induced by Fas
cross-linking in any of the Ad-transformed cell lines or in the
SV40-transformed HER or HaCaT control lines, although
apoptosis was readily detected in the BJAB and Jurkat
controls (results not shown).
Down-regulation of the steady-state levels of Fas and LFA-3
mRNAs in Ad12-transformed human cells
These results show that there are lower levels of cell
surface LFA-3 and Fas expressed by Ad12-compared to
Ad5-transformed cells. To determine whether these differ-
ences in cell surface protein expression were due to altered
steady-state levels of mRNA, we compared the levels of
LFA-3 and Fas mRNA in our panel of cell lines. Real-time
RT-PCR was used to quantitate mRNA levels relative to
non-virally transformed HaCaT cells. The results showed
that all Ad12-transformed cell lines expressed significantly
less Fas mRNA than the Ad5-transformed cell lines
(P values < 0.008) as shown in Fig. 4C. Fas mRNA levels
measured by real-time PCR correlated well with Fas surface
protein expression determined by flow cytometry (Figs. 4B
and C). A trend was also observed between LFA-3 surface
protein and mRNA levels, although differences in mRNA
levels were not statistically significant between the Ad12-
transformed cell lines and the Ad5-transformed cell lines
(Figs. 3B and C).
Ad12-transformed cells are more susceptible to LAK cell
lysis than Ad5-transformed cells
The data above show that human cells transformed by
Ad5 or Ad12 display differential expression of immuno-
modulatory molecules. We then determined whether there
was differential susceptibility of Ad5- and Ad12-trans-
formed cells to LAK cell-mediated killing. Human NK
cells were enriched from peripheral blood and cultured in
IL-2 to generate a LAK population. We co-cultured target
cells with LAK cells and determined target cell killing
using a flow cytometric assay. Flow cytometric methods for
the determination of cellular cytotoxicity have previously
been shown to provide an accurate assessment of cell deathcomparable to the chromium release assay (Kantakamala-
kul et al., 2003; Papa et al., 1988). The assay uses a
fluorescent DNA stain (7-AAD) that is excluded from live
cells. Target cells killed by LAK cells become permeable to
7-AAD and demonstrate increased fluorescence. Specific
lysis is calculated by subtraction of the spontaneous lysis
observed in the absence of LAK cells from the lysis
observed in their presence.
In an initial experiment we compared the ability of
increasing numbers of LAK cells to kill Ad12 HER 2 cells,
911 cells and control cell lines (Fig. 5A). LAK cells killed
K562 cells (an MHC class I negative, erythroleukemic cell
line frequently used to measure NK/LAK activity) in a dose-
dependent manner. The MHC class I positive B-cell
lymphoma cell line, BJAB, was relatively resistant to
killing. The Ad12 HER 2 cell line demonstrated dose-
dependent susceptibility to LAK cells but the Ad5-trans-
formed cell line 911 was relatively resistant. We then
repeated these killing assays using our panel of Ad-
transformed cell lines and controls at a fixed effector to
target (E:T) ratio of 5:1. We chose this ratio because it gave
good discrimination between the Ad12 HER 2 and 911 cells
in our initial experiment (Fig. 5A) while keeping the
requirement for LAK cells to a minimum. This ratio
allowed a greater number of killing assays to be processed
from a single LAK preparation. The results of these
experiments are shown in Fig. 5B. The three Ad12-
transformed cell lines demonstrated a greater susceptibility
to LAK cells than the three Ad5-transformed cells in a time-
dependent manner. The difference in susceptibility between
the Ad12- and Ad5-transformed cells is most evident after
24 h of co-culture (P values < 0.004). Similar results were
obtained with LAK cells from different donors (results not
shown). These results demonstrate that Ad5- and Ad12-
transformed human cells are differentially susceptible to
killing by LAK cells.Discussion
The E1A and E1B genes of Ad5 and Ad12 can transform
both rodent and human cells in vitro. However, while Ad12-
transformed cells are highly oncogenic in rodents, Ad5-
transformed cells are not. The cellular immune system plays
a key role in controlling tumor progression and the ability of
Ad12 to cause tumors in rodents reflects the ability of
Ad12-transformed rodent cells to evade both cytotoxic T
lymphocytes (CTL) and NK cells (Blair and Blair Zajdel,
2004). However, evasion of CTL by reduction of MHC
class I molecules is normally counterbalanced by an
increased susceptibility to NK cells. Paradoxically, Ad12-
transformed rodent cells exhibit an E1A-mediated resistance
to NK cell killing (Huvent et al., 1996; Kenyon and Raska,
1986; Raska and Gallimore, 1982; Sawada et al., 1985),
although the precise mechanism of this resistance has not
been established.
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the susceptibility of Ad5- and Ad12-transformed human
cells to killing by human NK cells. Significant advances in
our understanding of the mechanisms used by NK cells to
recognise and kill target cells has prompted us to compare
the susceptibility of Ad12- and Ad5-transformed human
cells to lysis by human LAK cells. To reduce the effects of
clonal variation on subsequent results, we performed these
studies using a panel of human embryonic retinoblasts
transformed with the E1A/E1B region of either Ad12 or
Ad5.
NK cells isolated from human peripheral blood express a
repertoire of inhibitory receptors (KIRs) for the classical
MHC class I molecules HLA-A, -B and -C. Reduced MHC
class I expression on target cells thus results in an increased
susceptibility to NK cell killing. Our results showed that
lower levels of MHC class I expression by the Ad12-
transformed cells (Fig. 2) correlated with increased suscept-
ibility to LAK cytolysis (Fig. 5B) when compared to Ad5-
transformed cells. The results presented here differ from
those previously reported using Ad-transformed rodent
cells, where both Ad5- and Ad12-transformed cells dem-
onstrated susceptibility to rodent LAK cells (Kenyon and
Raska, 1986; Kenyon et al., 1991), possibly reflecting the
differences in repertoires of NK receptor molecules between
rodents and humans (Barten et al., 2001).
The data presented here with Ad-transformed human
cells are in keeping with the ‘‘missing-self’’ hypothesis.
However, although ‘‘missing self’’ is regarded as a major
regulatory mechanism by which NK cells recognise target
cells, exceptions have been described. For example,
infection by HCMV, in common with other herpesviruses,
leads to down-regulation of MHC class I expression.
However, infection of cells with different HCMV isolates
indicated that MHC class I expression did not correlate
with NK cell susceptibility (Cerboni et al., 2000; Fletcher
et al., 1998). Thus, alterations in cell surface phenotype
other than classical MHC class I expression are important
in determining NK susceptibility of HCMV-infected cells.
What other phenotypic changes might occur in Ad12-
transformed cells to increase their susceptibility to NK
cells? A number of other molecules have been implicated
in regulating NK cell activity. For example, the non-
classical MHC class I molecule HLA-E binds to the
CD94-based NK receptors and can inhibit NK cell
activation (Braud et al., 1998; Lanier, 1998; Lee et al.,
1998). Whether Ad12 E1A mediates repression of
the HLA-E promoter is currently unknown. However,
HLA-E presents a very restricted repertoire of peptides
derived from the leader sequences of the HLA-A, -B and
-C molecules (Braud et al., 1998; Lee et al., 1998).
Repression of HLA-A, -B and -C genes in Ad12-trans-
formed cells reduces MHC class I expression (Fig. 2),
resulting in a reduction of the amount of MHC class I
leader sequence-derived peptide and a possible reduction
of surface HLA-E. Thus, reduced HLA-E expression byAd12-transformed cells may account for their increased
susceptibility to killing by NK cells compared to Ad5-
transformed cells. Interestingly, the HCMV UL40 protein
is known to increase HLA-E expression and subsequently
evade NK cells (Tomasec et al., 2000; Ulbrecht et al.,
2000). Alternatively, increased susceptibility to NK cells
could be explained by increased expression of an activat-
ing ligand such as those which bind to the natural
cytotoxicity receptors (Moretta et al., 2000) or ligands
for the NK cell receptor NKG2D (Bauer et al., 1999;
Cosman et al., 2001). In this case, higher expression of
activating ligands on Ad5-compared to Ad12-transformed
cells could account for the observed differences in LAK
cell susceptibility. The role of HLA-E expression and NK
cell activating ligands in determining differential sensitivity
of Ad5- and Ad12-transformed cells is currently under
investigation.
Adhesion of the NK cell to the target cell is crucial for
killing. Down-regulation of adhesion molecules on target
cells has also been linked with reduced NK cell
susceptibility. For example, KSHV encodes two proteins,
K3 and K5, which down-regulate the expression of MHC
class I, ICAM-1 and B7-2 molecules (Ishido et al., 2000).
This allows virus-infected cells to evade killing by CTL
and NK cells. In addition, LFA-3 is down-regulated in
HCMV-infected cells, leading to resistance to NK cells
(Fletcher et al., 1998). We therefore analysed the Ad12-
and Ad5-transformed cell lines for expression of ICAM-1
and LFA-3. Surface ICAM-1 was low or undetectable in
all of the Ad-transformed cells examined (data not shown).
Expression of LFA-3 was higher in the Ad5-compared to
Ad12-transformed cells (Fig. 3). Thus, LFA-3 expression
correlates with resistance to LAK cells. In HCMV
infection, a reduction in LFA-3 expression induces
resistance to NK cells (Fletcher et al., 1998). However,
our results show that Ad12-transformed cells, expressing
lower levels of LFA-3 than the Ad5-transformed cells, are
more susceptible to LAK cell lysis. Thus, LFA-3 expres-
sion and LAK susceptibility are inversely correlated in the
Ad-transformed cell lines whereas they are directly
correlated in HCMV-infected cells. Interestingly, a second
study of HCMV infection failed to establish a correlation
between expression of LFA-3 or ICAM-1 with suscep-
tibility of HCMV-infected cells to NK killing (Cerboni
et al., 2000).
The ability of Ad12 E1A to repress transcription from
MHC class I promoters has been well documented (Blair
and Blair Zajdel, 2004). Flow cytometry indicated that Fas
and LFA-3, like MHC class I, were expressed at lower
levels on Ad12-compared to Ad5-transformed human cells.
Furthermore, real-time PCR demonstrated that Fas mRNA
levels were also significantly lower in the Ad12-trans-
formed cells. These results suggest that Ad12 E1A might
repress the activity of the Fas and possibly the LFA-3
promoters and transcriptionally regulate these genes.
Microarray studies of adenovirus-transformed mouse cell
Fig. 4. Surface expression of Fas molecules on control, Ad5- and Ad12-transformed human cell lines. (A) Sample flow cytometric overlay histograms showing
Fas expression (black) compared to isotype-matched control (line). (B) Average mean fluorescence of surface Fas expression (shaded bars) compared to
isotype-matched control antibody (white bars). Error bars represent one standard deviation derived from five experiments. (C) Real-time PCR analysis of Fas
mRNA, normalised to HaCaT cells. Error bars represent one standard deviation.
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Fig. 5. Susceptibility of Ad-transformed and control human cell lines to killing by LAK cells. (A) Target cell death mediated by NK cells over a range of E:T
ratios after 6 h co-culture. Error bars show one standard deviation. (B) Collated and normalised data showing target cell death mediated by NK cells at an ET
ratio of 5:1 after 6 and 24 h co-culture. The results shown are average NK-mediated cell death derived from four experiments and the error bars show one
standard deviation. No NK cell-mediated cell death was seen in 293 cells after 6 h incubation.
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150 ESTs which were differentially expressed between
Ad5- and Ad12-transformed cells (Guan et al., 2003),
indicating that many target genes exist for the E1A-
mediated transformation process. Our results, using human
cells, suggest that differences in the patterns of gene
expression which occur between Ad5- and Ad12-trans-
formed cells are able to render these transformed cells
differentially susceptible to LAK cells.
Despite down-regulation of Fas, Ad12-transformed cells
are more susceptible to LAK cells than Ad5-transformed
cells. However, LAK cells can kill target cells through the
granule exocytosis pathway (mediated by granzymes and
perforin) as well as through other TNF-related receptor
pathways (Russell and Ley, 2002). Expression of the E1B
19-kDa protein could influence the susceptibility of Ad-transformed cells to LAK cell-mediated killing. E1B has
been shown to have anti-apoptotic functions (Cuconati and
White, 2002), which may mediate resistance to LAK cell-
induced apoptosis. However, despite small variations in
E1B transcript levels within the Ad5- and Ad12-trans-
formed cell lines, there was no detectable impact on LAK-
mediated killing. For example, HER RIC C4 and HER RIC
C7 express higher levels of Ad12 E1B transcripts than
Ad12 HER 2 (Fig. 1B) but are more sensitive to LAK-
mediated killing (Fig. 5B) arguing against a protective role
for the E1B 19-kDa protein in these cell lines. The system
used here analyses the combined effects of the E1A and
E1B 19-kDa proteins on immunomodulatory molecules and
susceptibility to LAK cells. It will be interesting to define
the roles of individual E1A and E1B proteins in immuno-
modulation.
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Ad12-transformed human cells exhibit differential expres-
sion of cell surface MHC class I, LFA-3 and Fas
molecules. Changes in the expression of immunomodula-
tory molecules would be expected to lead to differences in
the recognition and killing of these cells by immune
effector cells and we have demonstrated that Ad12-
transformed human cells are more susceptible to LAK
cell lysis than Ad5-transformed human cells. However, the
role of LFA-3, Fas and MHC class I in this process is
currently unknown. The reduction in cell surface MHC
class I observed in Ad12-transformed cells coupled with
their increased susceptibility to LAK cells is in agreement
with the ‘‘missing-self’’ hypothesis. However, a plethora of
target cell molecules are known to regulate NK cell
susceptibility and the mechanism by which Ad12 and Ad5
E1A/E1B molecules modulate these effects requires further
study.Materials and methods
Cell culture
Ad12 HER 2 (Grand et al., 1987), HER RIC C4 and
HER RIC C7 (Rademaker et al., 2002) are human
embryonic retinoblast cell lines transformed with the E1
region of Ad12. Two human embryonic retinoblast cell
lines transformed by the E1 region of Ad5 were also
studied: 911 (Fallaux et al., 1996) and HER Xho C2. 293
is a human embryonic kidney cell line transformed by
Ad5 (Graham et al., 1977). HER C SV40 T3.2 is an
SV40-transformed human embryonic retinoblast cell line.
BJAB and Jurkat are human cell lines from the B cell and
T cell lineages, respectively, and HaCaT is a human
keratinocyte cell line. K562 is a human erythroleukemic
cell line. Cell lines were kindly provided by colleagues
(see Acknowledgments) or obtained from ECACC, Salis-
bury, UK.
HaCaT, Ad12 HER 2, HER RIC C4, HER RIC C7, 911
and HER Xho C2 were cultured in DMEM (GIBCO,
Paisley, UK) supplemented with 10% FCS, 100 U/ml
penicillin, 100 Ag/ml streptomycin and 2 mM l-glutamine.
293 cells were cultured in complete DMEM containing 10%
NBCS. BJAB and K562 were maintained at less than 0.5 
106 cells/ml in RPMI 1640 (GIBCO, Paisley, UK)
supplemented with 10% FCS, 100 U/ml penicillin, 100
Ag/ml streptomycin and 2 mM l-glutamine. All cell lines
were maintained in a humidified incubator at 37 -C and 5%
CO2.
Antibodies
The following primary antibodies were used for flow
cytometry: MHC class I (W6/32; Dako), LFA-3 (BRIC-5;
Serotec), ICAM-1 (6.5B5; Dako) and Fas (LOB 3/17;Serotec). FITC-conjugated rabbit anti-mouse IgG (Sigma)
was used as the secondary antibody in all experiments.
Primary antibodies for Western blotting were as follows:
Ad5 E1A (M73; Oncogene Science), Ad12 E1A (163; a
gift from Roger Grand, University of Birmingham, UK),
Ad5/Ad12 E1B 19-kDa (EC3; Blair Zajdel et al., 1985)
and actin (JLA 20; Developmental Studies Hybridoma
Bank, University of Iowa). Secondary antibodies for
Western blots were sheep anti-mouse-HRP, rabbit anti-
rat-HRP (both from Sigma) and goat anti-mouse IgM-HRP
(Serotec) as appropriate.
Indirect immunofluorescence
2  105 cells in suspension were pre-blocked with 10%
normal goat serum (Vector Laboratories, Peterborough, UK)
for 10 min at room temperature. The cells were washed with
PBS before labelling with primary antibody for 30 min at
37 -C. The cells were then washed four times with PBS and
labelled with secondary antibody, again for 30 min at 37 -C.
The cells were then analysed by flow cytometry on a Becton
Dickinson FACScalibur. Events were gated on the viable
cell population and mean fluorescence determined using
CellQuest software (Becton Dickinson, Oxford, UK). Data
were collated from at least five experiments and analysed by
pair-wise Student’s t test.
Immunoblotting
Cells were harvested by trypsinisation or centrifugation,
resuspended in lysis buffer (150 mM NaCl, 1% NP40,
0.5% sodium deoxycholate, 0.1% sodium dodecyl sul-
phate, 50 mM Tris–HCl pH 8.0 and complete protease
inhibitors (Roche, Welwyn Garden City, UK), and incu-
bated on ice for 10 min. After clarification by centrifuga-
tion, protein concentrations were estimated using the Bio-
Rad DC protein assay kit and adjusted to 20 mg/ml.
Lysates (10 Al/lane) were separated on 12% SDS–PAGE
gels, electrotransferred onto PVDF membrane and immu-
noblotted with the appropriate antibodies. Antibodies were
revealed with peroxidase-conjugated secondary antibodies
and an enhanced chemiluminescence detection system
(ECL, Amersham, UK).
Enrichment of peripheral blood NK cells and LAK cell
preparation
Peripheral blood NK cells were isolated from blood
obtained from normal human volunteers using the human
NK cell isolation kit (Miltenyi Biotech, Bisley, UK)
according to the manufacturer’s instructions. The cells
were cultured for 7–14 days in DMEM medium supple-
mented with 5% FCS, 10% human AB serum (Harlan
Seralabs, Loughborough, UK) and 50 U/ml human rIL-2
(Sigma, Poole, UK). Cells were then analysed by flow
cytometry for expression of the NK cell markers CD56
Ad5 E1B FP: 5V-AGG TTT ACT GGC CCC AAT TTT AG-3V
Ad5 E1B RP: 5V-ACC CAT AGA AGC TTA CAC CGT GTA G-3V
Ad12 E1B FP: 5V-TCA GGA AAA AGT GGT CAG ATC CTT-3V
Ad12 E1B RP: 5V-AAT ATG GTT GCC AAA AAA GCA ATA G-3V
Fas FP: 5V-GAT GGC CAA TTC TGC CAT AAG-3V
Fas RP: 5V-GTC TGG TTC ATC CCC ATT GAC T-3V
LFA-3 FP: 5V-CCA ATG CAT GAT ACC AGA GCA T-3V
LFA-3 RP: 5V-ATA TAC TGG TTG AGT TAC GTT TAC ATT
GC-3V
PBG-D FP: 5V-CTG CAA CGG CGG AAG AA-3V
PBG-D RP: 5V-AGC TGG CTC TTG CGG GTA C-3V
GAPDH FP: 5V-GAA GGT GAA GGT CGG AGT-3V
GAPDH RP: 5V-GAA GAT GGT GAT GGG ATT TC-3V
G. Bottley et al. / Virology 338 (2005) 297–308 307and CD94 and the T cell marker CD3, which revealed that
>75% of cells were CD56+ve/CD94+ve and all cells were
CD3ve.
LAK cell cytotoxicity assay
Target cells were plated in 24-well plates at a density of
105 cells/well in 1 ml of growth medium and allowed to
adhere overnight. LAK cells were fluorescently labelled
using the Vybrant DiI system (Molecular Probes, Cam-
bridge, UK) according to the manufacturer’s instructions
and pre-incubated for 30 min before addition to target
cells. LAK cells were added at appropriate numbers per
well in 1 ml of RPMI growth medium. The co-cultures
were incubated at 37 -C and 5% CO2 for 6 or 24 h.
Medium from wells containing suspension target cells was
transferred directly to microcentrifuge tubes. The over-
laying medium of adherent target cells was then removed
and each well gently washed with 100 Al PBS. The cells
were then trypsinised from the plate and the trypsin
neutralised with the original medium from the appropriate
well. All cells were washed once in PBS and then
incubated on ice in 300 Al of 20 Ag/ml 7-aminoactinomy-
cin-D (7-AAD; Sigma, Poole, UK) for 20 min before
analysis by flow cytometry.
Cell debris was gated out from the size/granularity dot-
plot and the remaining events plotted on a granularity vs.
DiI fluorescence (FL2). A further gate was applied to
analyse the DiIve events (target cells) and the percentage of
7-AAD positive target cells (dead cells) was determined
from the 7-AAD histogram. Specific lysis was calculated by
subtracting lysis in the absence of LAK cells (spontaneous
lysis) from lysis in their presence and expressing the results
as a percentage of the target population killed. Data were
collated from at least five separate experiments and analysed
by pair-wise Student’s t test. Killing assay results were
confirmed using LAK cells derived from independent
donors.
Real-time RT-PCR
Total RNA was prepared from cell pellets with TRIzol
(Gibco, Paisley, UK) and cDNA synthesised with Super-
script II (Gibco, Paisley, UK) according to the manufac-
turer’s protocols. Real-time PCR was performed using the
SybrGreen system (Applied Biosystems, Foster City, CA,
USA) on an ABI Prism Geneamp 5700 thermal cycler.
The threshold cycle values were normalised to the
housekeeping genes non-erythropoietic porphobilinogen
deaminase (PBG-D) or glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) and the expression relative to HaCaT
cells calculated using the formula 2DDCT according to
manufacturer’s recommendations (Applied Biosystems,
Foster City, CA, USA). Data were collated from at least
three experiments and analysed by pair-wise Student’s
t test.The following forward (FP) and reverse (RP) primers
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